{"id":1685,"date":"2015-06-29T22:58:42","date_gmt":"2015-06-29T21:58:42","guid":{"rendered":"https:\/\/tris.sambrownprojects.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/"},"modified":"2023-08-23T14:19:22","modified_gmt":"2023-08-23T13:19:22","slug":"tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand","status":"publish","type":"post","link":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/","title":{"rendered":"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin®<\/sup> Brand"},"content":{"rendered":"

MONMOUTH JUNCTION, N.J., June 29, 2015; –<\/p>\n

Tris Pharma, Inc. (“Tris”) today announced that it has entered into a license, supply, and distribution agreement with Pfizer Consumer Healthcare.<\/p>\n

Under the terms of the agreement, Pfizer Consumer Healthcare will commercialize Tris\u2019 extended release dextromethorphan cough syrup under the Robitussin\u00ae<\/sup> Brand. In exchange for providing Pfizer Consumer Healthcare U.S. branded rights to its protected intellectual property for an extended release dextromethorphan formulation, Tris will receive an upfront payment, milestone payments and sales-based royalties. Tris will be responsible for manufacturing and regulatory activities while Pfizer Consumer Healthcare will manage sales, marketing, and distribution.<\/p>\n

Pfizer Consumer Healthcare plans to launch extended-release Robitussin in July, prior to the 2015-2016 cough\/cold season.<\/p>\n

Dextromethorphan is indicated for the treatment of cough due to minor throat and bronchial irritation. According to the National Institute of Health (NIH), each year there are millions of cough\/cold suffers and for many of these patients, self-medicating with long-acting dextromethorphan will be the preferred option.<\/p>\n

Ketan Mehta, CEO of Tris commented, \u201cThe U.S. cough and cold market has been ripe for innovation and when you consider that market research shows most patients prefer long-lasting relief in the form of a liquid, rather than a solid pill, our technology is well positioned to address this market. We are delighted to partner with Pfizer Consumer Healthcare and have our product marketed under the Robitussin\u00ae<\/sup> brand, the #1 pharmacist recommended for cough, cold and flu combinations.\u201d<\/p>\n

About Tris Pharma:<\/strong><\/p>\n

Tris Pharma is a specialty pharmaceutical company focused on drug delivery technologies based products including difficult-to-formulate or complex generic products. Through its OralXR+ platform, Tris has pioneered the delivery of sustained release in the liquid, chewable\/ODT and strip dosage forms so patients do not have to swallow a pill. Tris’ Nobuse platform provides abuse-deterrence for opioids and other abuse-prone drugs. Tris’ R&D and manufacturing facilities are located in Monmouth Junction, New Jersey.<\/p>\n

For more information visit\u00a0https:\/\/www.trispharma.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

MONMOUTH JUNCTION, N.J., June 29, 2015; – Tris Pharma, Inc. (“Tris”) today announced that it has entered into a license, supply, and distribution agreement…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_wp_rev_ctl_limit":""},"categories":[29],"tags":[],"class_list":["post-1685","post","type-post","status-publish","format-standard","hentry","category-partners"],"acf":[],"featured_image_src":{"landsacpe":false,"list":false,"medium":false,"full":false},"yoast_head":"\nTris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand - Tris Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand - Tris Pharma\" \/>\n<meta property=\"og:description\" content=\"MONMOUTH JUNCTION, N.J., June 29, 2015; - Tris Pharma, Inc. ("Tris") today announced that it has entered into a license, supply, and distribution agreement...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/\" \/>\n<meta property=\"og:site_name\" content=\"Tris Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2015-06-29T21:58:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-23T13:19:22+00:00\" \/>\n<meta name=\"author\" content=\"rajeshlohakare@sambrown.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rajeshlohakare@sambrown.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/\",\"url\":\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/\",\"name\":\"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand - Tris Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.trispharma.com\/#website\"},\"datePublished\":\"2015-06-29T21:58:42+00:00\",\"dateModified\":\"2023-08-23T13:19:22+00:00\",\"author\":{\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.trispharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.trispharma.com\/#website\",\"url\":\"https:\/\/www.trispharma.com\/\",\"name\":\"Tris Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.trispharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2\",\"name\":\"rajeshlohakare@sambrown.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g\",\"caption\":\"rajeshlohakare@sambrown.com\"},\"sameAs\":[\"http:\/\/tris.sambrownprojects.com\"],\"url\":\"https:\/\/www.trispharma.com\/author\/rajeshlohakaresambrown-com\/\"}]}<\/script>\n","yoast_head_json":{"title":"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand - Tris Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/","og_locale":"en_GB","og_type":"article","og_title":"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand - Tris Pharma","og_description":"MONMOUTH JUNCTION, N.J., June 29, 2015; - Tris Pharma, Inc. (\"Tris\") today announced that it has entered into a license, supply, and distribution agreement...","og_url":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/","og_site_name":"Tris Pharma","article_published_time":"2015-06-29T21:58:42+00:00","article_modified_time":"2023-08-23T13:19:22+00:00","author":"rajeshlohakare@sambrown.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rajeshlohakare@sambrown.com","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/","url":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/","name":"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand - Tris Pharma","isPartOf":{"@id":"https:\/\/www.trispharma.com\/#website"},"datePublished":"2015-06-29T21:58:42+00:00","dateModified":"2023-08-23T13:19:22+00:00","author":{"@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2"},"breadcrumb":{"@id":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.trispharma.com\/tris-pharma-and-pfizer-consumer-healthcare-enter-into-agreement-to-commercialize-12-hour-extended-release-dextromethorphan-cough-syrup-under-the-robitussin-brand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.trispharma.com\/"},{"@type":"ListItem","position":2,"name":"Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand"}]},{"@type":"WebSite","@id":"https:\/\/www.trispharma.com\/#website","url":"https:\/\/www.trispharma.com\/","name":"Tris Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.trispharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2","name":"rajeshlohakare@sambrown.com","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g","caption":"rajeshlohakare@sambrown.com"},"sameAs":["http:\/\/tris.sambrownprojects.com"],"url":"https:\/\/www.trispharma.com\/author\/rajeshlohakaresambrown-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1685"}],"collection":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/comments?post=1685"}],"version-history":[{"count":1,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1685\/revisions"}],"predecessor-version":[{"id":1739,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1685\/revisions\/1739"}],"wp:attachment":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/media?parent=1685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/categories?post=1685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/tags?post=1685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}